An Ultrasensitive Biosensor for Probing Subcellular Distribution and Mitochondrial Transport of l-2-Hydroxyglutarate

  • Adv Sci (Weinh). 2024 Jul 15:e2404119. doi: 10.1002/advs.202404119.
Zhaoqi Kang  1 Shuang Hou  1 Kaiyu Gao  1 Yidong Liu  1 Ning Zhang  2 Zhiqing Fang  3 Wen Zhang  4 Xianzhi Xu  1 Rong Xu  1 Chuanjuan Lü  1 Cuiqing Ma  1 Ping Xu  5 Chao Gao  1
Affiliations
  • 1. State Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, P. R. China.
  • 2. Department of Breast Surgery, General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250100, P. R. China.
  • 3. Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250100, P. R. China.
  • 4. Institute of Medical Sciences, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250100, P. R. China.
  • 5. State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, and School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, P. R. China.
Abstract

l-2-Hydroxyglutarate (l-2-HG) is a functionally compartmentalized metabolite involved in various physiological processes. However, its subcellular distribution and mitochondrial transport remain unclear owing to technical limitations. In the present study, an ultrasensitive l-2-HG biosensor, sfLHGFRH, composed of circularly permuted yellow fluorescent protein and l-2-HG-specific transcriptional regulator, is developed. The ability of sfLHGFRH to be used for analyzing l-2-HG metabolism is first determined in human embryonic kidney cells (HEK293FT) and macrophages. Then, the subcellular distribution of l-2-HG in HEK293FT cells and the lower abundance of mitochondrial l-2-HG are identified by the sfLHGFRH-supported spatiotemporal l-2-HG monitoring. Finally, the role of the l-glutamate transporter SLC1A1 in mitochondrial l-2-HG uptake is elucidated using sfLHGFRH. Based on the design of sfLHGFRH, another highly sensitive biosensor with a low limit of detection, sfLHGFRL, is developed for the point-of-care diagnosis of l-2-HG-related diseases. The accumulation of l-2-HG in the urine of patients with kidney Cancer is determined using the sfLHGFRL biosensor.

Keywords
biosensor; l‐2‐hydroxyglutarate; metabolism; mitochondrial transport; point‐of‐care testing.
Products